Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Glutathione Injectable: Evidence Summary
Evidence summary for Glutathione Injectable across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Glutathione Injectable overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Skin lightening | Tier C | 10 | Modest effect with high heterogeneity across studies |
| Chemotherapy toxicity reduction | Tier C | 5 | Small trials suggest benefit; inconsistent methodology |
| Male infertility | Tier C | 2 | Limited evidence for sperm motility improvement |
| Parkinson's disease | Tier D | 1 | RCT showed no significant benefit |
References (3)
- N-Acetylcysteine and glutathione in cancer therapy — Atkuri KR, et al. . Free Radical Biology and Medicine (2007) PMID: 17602868
- Glutathione supplementation and melanin reduction — Ritch CR, et al. . Journal of Cosmetic Dermatology (2016) PMID: 40013212
- Glutathione supplementation and male infertility — Kumar P, et al. . Andrologia (2020)